Trials / Completed
CompletedNCT03390114
Cognitive Behavioral Therapy to Treat Insomnia in Persons With HIV Infection
Internet-Based Cognitive Behavioral Therapy to Treat Insomnia in HIV: A Pilot Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this preliminary study is to determine the efficacy of an internet-based treatment program for insomnia for HIV-infected persons.
Detailed description
The primary objective of this pilot trial is to compare 10-week changes in Insomnia Severity Index (ISI) scores in HIV-infected adults with clinically relevant insomnia severity and who are already receiving virologically suppressive antiretroviral therapy (ART) and are then randomized to either treatment with the SHUTi cognitive behavioral therapy program or to Usual Care (UC). A total of 100 persons with HIV may be screened to identify the 32 participants to be enrolled and randomized into the pilot trial. These participants will be ≥ 18 years old, have been receiving antiretroviral therapy with an HIV viral load \< 75 copies/mL within three months of the Entry Visit, and have an ISI score ≥ 15 within three months of the Entry Visit. These participants will be randomized 1:1 (stratified by age \<40 vs. ≥ 40 years) to either insomnia treatment with the SHUTi cognitive behavioral therapy program (N=16) or usual care (N=16).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | SHUTi | SHUTi consists of six, 40-minute, weekly sessions during which the intervention components of stimulus control, sleep restriction, sleep hygiene, cognitive restructuring, and relapse prevention are delivered. Each SHUTi session has the same structure: the main content, a homework screen with options, and a summary of the main points. |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2019-07-31
- Completion
- 2019-12-31
- First posted
- 2018-01-04
- Last updated
- 2021-02-21
- Results posted
- 2021-02-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03390114. Inclusion in this directory is not an endorsement.